acute pain epidemiology forecast

DelveInsight's "Acute Pain- Epidemiology Forecast-2034" report delivers an in-depth understanding of the acute pain, historical and forecasted epidemiology as well as the acute pain market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Acute Pain Understanding

The DelveInsight’s acute pain market report gives a thorough understanding of the disease. Pain is an uncomfortable sensation that usually signals an injury or illness and tells the body that something is wrong. It is a sensory symptom of tissue damage or disorder that can be either acute or chronic. International Association for the Study of Pain (IASP) defines acute pain as sudden pain that starts sharp or intense and is a warning sign of disease or threat to the body. It is caused by injury, surgery, illness, trauma, or painful medical procedures and generally lasts from a few minutes to less than 6 months. Acute pain usually disappears whenever the underlying cause is treated or healed. Acute pain can vary significantly and can be categorized into two main types: spontaneous insult or trauma and elective or planned procedures.

Acute pain is usually severe, comes on quickly, and lasts a fairly short time which is a sign that the body has been injured in some way and pain generally goes away as the injury heals. Most common symptoms associated with acute pain include flu-like symptoms (fever, chills, sore throat, and cough), fatigue, numbness, muscle spasms, insomnia, weight loss, anxiety, depression, sharp pain, throbbing, burning, etc. A person could suffer from acute pain due to any of the following reasons including blunt trauma, broken bones, surgery, dental work, childbirth, cuts and infections, burns, strained muscle, sprains of a body part.

Doctors diagnose the pain by discussing one’s symptoms, the intensity and location of pain, and the history of injury, surgery, or illness. Young patients may be asked to rate their pain intensity using the pain scale which include VAS, VRS, NPRS, etc. Other diagnostic tests include blood tests, X-rays, CT scans, MRI, ultrasound, etc.

Acute Pain Epidemiology

The acute pain epidemiology division provides insights about historical and current acute pain patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides a historical as well as forecasted acute pain epidemiology scenario in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034.

The disease epidemiology covered in the report provides historical as well as forecasted acute pain epidemiology [segmented as Total Incidence of acute pain, Total Diagnosed Incident Cases of acute pain, Type-specific Diagnosed Incident Cases of acute pain, Severity-specific Diagnosed Incident Cases of acute pain, and Total Treated Cases of acute pain] in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034.

Country Wise- Acute Pain Epidemiology

The epidemiology segment also provides the acute pain epidemiology data and findings across the United States, the EU4 and the UK, and Japan.

• As per the DelveInsight estimates, there were approximately 100 million cases in the US in 2021. These cases are expected to grow with a moderate CAGR in the forecast period 2022–2034.
• The total incident cases of acute pain in EU4 and the UK are projected to increase by 2034, at a moderate CAGR during the forecast period (2021–2034).
• The total incident cases of acute pain in Japan are projected to increase by 2034, at a moderate CAGR during the forecast period (2021–2034).

KOL- Views

To keep up with the current acute pain patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the acute pain domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.

Scope of the Report

• The report covers the descriptive overview of acute pain, explaining its causes, symptoms, and pathophysiology.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU4 countries and the United Kingdom, and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of pain.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM by Total Incidence of acute pain, Total Diagnosed Incident Cases of acute pain, Type-specific Diagnosed Incident Cases of acute pain, Severity-specific Diagnosed Incident Cases of acute pain, and Total Treated Cases of acute pain in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034

Report Highlights

• The companies and academics are working to assess challenges and seek opportunities that could influence acute pain R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for acute pain.
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.

Acute Pain Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Acute Pain Epidemiology Segmentation

Key Questions

Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of acute pain?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU4 and the United Kingdom, and Japan?
• What is the historical acute pain patient pool in seven major markets covering the United States, EU4 and the United Kingdom, and Japan?
• What would be the forecasted patient pool of acute pain in seven major markets covering the United States, EU4 and the United Kingdom, and Japan?
• Where will be the growth opportunities in the 7MM concerning the patient population about acute pain?
• Out of all 7MM countries, which country would have the highest incident population of acute pain during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the acute pain Disease market
• To understand the future market competition in the acute pain Disease market
• Organize sales and marketing efforts by identifying the best opportunities for acute pain Disease in the US, the EU4 and the UK, and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for the acute pain Disease market
• To understand the future market competition in the acute pain Disease market